Repare Therapeutics Inc. Business Operations Contracts & Agreements
10 Contracts & Agreements
- Collaboration Agreements (10 contracts)
- Fifth Amendment to Collaboration and License Agreement by and between the registrant and Bristol-Myers Squibb Company, dated March 14, 2024 (Filed With SEC on May 7, 2024)
- Fourth Amendment to Collaboration and License Agreement by and between the registrant and Repare Therapeutics USA Inc. and Bristol-Myers Squibb Company, dated May 12, 2023 (Filed With SEC on August 9, 2023)
- Second Amendment to Collaboration and License Agreement by and between the registrant, Repare Therapeutics Inc. and Hoffmann-La Roche Inc. and F. Hoffmann-La Roche Ltd. dated... (Filed With SEC on November 9, 2022)
- First Amendment to Collaboration and License Agreement by and between the registrant, Repare Therapeutics Inc. and Hoffmann-La Roche Inc. and F. Hoffmann-La Roche Ltd. dated... (Filed With SEC on November 9, 2022)
- First Amendment to Research Services, License and Collaboration Agreement by and between the registrant and Ono Pharmaceutical Co., Ltd., dated October 29, 2021 (Filed With SEC on November 10, 2021)
- Third Amendment to Collaboration and License Agreement by and between the registrant, Repare Therapeutics USA Inc. and Bristol-Myers Squibb Company, dated November 20, 2020 (Filed With SEC on March 4, 2021)
- Second Amendment to Collaboration and License Agreement by and between the registrant, Repare Therapeutics Inc. and Bristol-Myers Squibb Company, dated September 24, 2020 (Filed With SEC on November 12, 2020)
- First Amendment to Collaboration and License Agreement by and between the registrant, Repare Therapeutics USA Inc. and Bristol-Myers Squibb Company, dated July 22, 2020 (Filed With SEC on August 13, 2020)
- Collaboration and License Agreement by and between the registrant, Repare Therapeutics USA Inc. and Bristol-Myers Squibb Company, dated May 26, 2020 (Filed With SEC on May 29, 2020)
- Research Services, License and Collaboration Agreement by and between the registrant and Ono Pharmaceutical Co., Ltd., dated January 31, 2019 (Filed With SEC on May 29, 2020)
